Seeing Is Believing
Currently out of the existing stock ratings of David Adlington, 33 are a HOLD (47.14%), 19 are a BUY (27.14%), 18 are a SELL (25.71%).
Analyst David Adlington, currently employed at JPMORGAN, carries an average stock price target met ratio of 41.35% that have a potential upside of 38.75% achieved within 248 days.
David Adlington’s has documented 135 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on FMS, Fresenius Medical Care at 06-Nov-2024.
Analyst best performing recommendations are on AMFPF (AMPLIFON S.P.A).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 10/19/2021. The price target of $42.31 was fulfilled within 3 days with a profit of $2.5 (6.28%) receiving and performance score of 20.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$30
$0.98 (3.38%)
$25
17 days ago
(12-May-2025)
10/14 (71.43%)
$1.89 (6.72%)
286
Sell
6 months 23 days ago
(06-Nov-2024)
4/15 (26.67%)
$12.9 (76.15%)
244
Hold
9 months 28 days ago
(31-Jul-2024)
1/2 (50%)
$21.74 (116.82%)
916
Sell
$40.12
1 years 3 months 6 days ago
(23-Feb-2024)
0/5 (0%)
$22.97 (133.94%)
Hold
$34
1 years 6 months 5 days ago
(24-Nov-2023)
0/2 (0%)
$15.99 (88.78%)
What Year was the first public recommendation made by David Adlington?